Pemvidutide
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
Altimmune · Phase 2 · Completed · Enrollment 100
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.